DNA X, Inc. (SONM)
NASDAQ: SONM · Real-Time Price · USD
3.380
+0.060 (1.81%)
At close: Aug 19, 2026, 4:00 PM EDT
3.700
+0.320 (9.47%)
After-hours: Aug 19, 2026, 6:51 PM EDT

DNA X Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---93.6369.8354.57
Revenue Growth
---34.09%27.96%-14.72%
Gross Profit
---19.3211.626.41
Operating Income
-8.15-5.41-3.10.51-13.09-38
Net Income
-14.78-20.66-33.65-0.09-14.09-38.63
Earnings Per Share
-15.43-28.58-128.37-0.38-87.77-734.62
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.21.35.349.413.2111.23
Total Debt
1.075.07--0.210.21
Net Cash (Debt)
0.12-3.765.349.41311.02
Net Cash Growth
---43.14%-27.71%17.98%-49.41%
Net Cash Per Share
0.13-5.2120.3839.4581.00209.56

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-17.39-23.53-8.49-4.05-12.36-38.48
Capital Expenditures
---0.21-0.04-0.01-0.05
Free Cash Flow
-17.39-23.53-8.7-4.09-12.37-38.52
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---20.64%16.64%11.75%
Operating Margin
---0.55%-18.75%-69.64%
Pretax Margin
---0.30%-19.91%-70.48%
Profit Margin
----0.10%-20.17%-70.78%
FCF Margin
----4.37%-17.71%-70.59%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-6.286.2814.7027.4227.42
PS Ratio
---0.340.250.27